Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Loriot, Yohann; Necchi, Andrea; Hoon Park, Se; García-Donás, Jesús; Huddart, Robert; F. Burgess, Earle; T. Fleming, Mark; Rezazadeh, Arash; Mellado, Begoña; Varlamov, Sergey; Joshi, Monika; Durán, Ignacio; T. Tagawa, Scott; Zakharia, Yousef; Zhong, Bob; Stuyckens, Kim; Santiago-Walker, Ademi; De Porre, Peter; O’Hagan, Anne; Narayan Avadhani, Anjali; O. Siefker‐Radtke, Arlene

doi:10.1056/nejmoa1817323

Public

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Published in New England Journal of Medicine • Jul 24, 2019

Authors:

Yohann Loriot

Andrea Necchi

Se Hoon Park

Abstract

BACKGROUND: alterations. METHODS: alterations. All the patients had a history of disease progression during or after at least one course of chemotherapy or within 12 months after neoadjuvant or adjuvant chemotherapy. Prior immunotherapy was allowed. We initially randomly assigned the patients to rec...

Subject

Urothelial carcinoma

Metastatic Urothelial Carcinoma

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!